Nation
AstraZeneca India gets CDSCO approval for ‘Palivizumab’ preventive therapy against respiratory syncytial virus
AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, has received marketing approval from the Central Drugs Standard Control Organisation (CDSCO) Tap to...